Pan-Cancer Analysis Reveals AEBP1-Collagen Co-Expression and Its Potential Role in CAF-Mediated Tumor Stiffness
Authors:
- Shohei SekiguchiSSShohei Sekiguchi
- Akira YorozuAYAkira Yorozu
- Megumi WatanabeMWMegumi Watanabe
- Fumika OkazakiFOFumika Okazaki
- Satoshi OhwadaSOSatoshi Ohwada
- Eiichiro YamamotoEYEiichiro Yamamoto
- Takeshi NiinumaTNTakeshi Niinuma
- Hiroshi KitajimaHKHiroshi Kitajima
- Kazuya IshiguroKIKazuya Ishiguro
- Mitsunobu SaitoMSMitsunobu Saito
- Masahiro KaiMKMasahiro Kai
- Masashi IdogawaMIMasashi Idogawa
Open Access
- 27 November 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11474
Abstract
Cancer-associated fibroblasts (CAFs) are critical components of the tumor microenvironment that promote cancer progression and immune evasion. Adipocyte enhancer-binding protein 1 gene (AEBP1), which encodes aortic carboxypeptidase-like protein (ACLP), has been implicated in tissue remodeling and fibrosis, yet its role in CAF biology across cancers remains poorly understood. Here, we performed a pan-cancer transcriptomic analysis using The Cancer Genome Atlas (TCGA) and found that AEBP1 expression strongly correlates with expression of collagen family genes in the majority of solid tumors. Integration of single-cell RNA-sequencing datasets from breast and pancreatic cancers revealed that AEBP1 is predominantly expressed in CAFs, where it is co-expressed with collagens and CAF marker genes. Functional experiments using three-dimensional (3D) spheroids composed of oral squamous cell carcinoma (OSCC)-derived CAFs showed that AEBP1 knockdown significantly reduced spheroid stiffness without altering their morphology or size, indicating that ACLP contributes to the mechanical properties of tumor tissues. Together with earlier findings linking AEBP1/ACLP to reduced CD8+ T-cell infiltration, our results suggest that stromal AEBP1/ACLP enhances both extracellular matrix stiffness and immune suppression and highlights AEBP1/ACLP as a potential therapeutic target through which to remodel the tumor microenvironment and improve anti-tumor immunity.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (JSPS) Kakenhi (24K20001, 24K12676, 25K20381, 24K11157, 23K24186, 25K22694)
This publication has 39 references indexed in Scilit:
- AEBP1-GLI1 pathway attenuates the FACT complex dependency of bladder cancer cell survivalBiochemistry and Biophysics Reports, 2025
- AEBP1 or ACLP, which is the key factor in inflammation and fibrosis?International Journal of Biological Macromolecules, 2025
- AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signalingNeoplasia, 2024
- Cancer-associated fibroblast classification in single-cell and spatial proteomics dataNature Communications, 2023
- Activated fibroblasts in cancer: Perspectives and challengesCancer Cell, 2023
- ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancerCancer Letters, 2022
- AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF‐κB pathwayMolecular Carcinogenesis, 2019
- A biallelic truncating AEBP1 variant causes connective tissue disorder in two siblingsAmerican Journal of Medical Genetics Part A, 2018
- Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos SyndromeThe American Journal of Human Genetics, 2018
- Gene structure and expression of the mouse adipocyte enhancer-binding proteinGene, 2001